Open AccessTiotropium Respimat® improves physical functioning in chronic obstructive pulmonary disease
Author(s) -
Heike Rau-Berger,
Mitfessel,
Glaab
Publication year - 2010
Publication title -
international journal of copd
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.394
H-Index - 67
eISSN - 1178-2005
pISSN - 1176-9106
DOI - 10.2147/copd.s14082
Subject(s) - medicine , tolerability , copd , tiotropium bromide , observational study , pulmonary disease , adverse effect , inhaler , physical therapy , pulmonary function testing , dry powder inhaler , lung function , asthma , lung
This observational study with tiotropium Respimat® was performed in a real-life setting to investigate its effectiveness with regard to physical functioning and tolerability.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom